Tennessee scored two touchdowns in the final 2:40 to beat Miami last year – in a game that ruined the Dolphins’ chances to win the AFC East and left them subjected to a playoff loss in frigid ...

A new study reveals that glucagon-like peptide-1 receptor agonists (GLP-1), which include weight loss and diabetes meds ...

New, popular injectable weight loss drugs — GLP-1 drugs — are highly effective at reducing obesity and, probably, the health ...

Weight-loss and diabetes drugs like Ozempic, Wegovy, Mounjaro or Zepbound appear to help people battle alcoholism and opioid ...

Weight loss medications such as Ozempic may be able to cut drug and alcohol abuse in half, according to a new study from the ...

Not everybody loses the same amount of weight on medications such as Ozempic and Saxenda—treatment indication, dosage, and ...

Researchers from Loyola University Chicago are adding to the growing evidence suggesting that medications like Ozempic can ...

A new study found a link between new popular GIP/GLP-1 receptor agonists and a reduced rate of overdose or intoxication in ...

the Brewers’ soul crushing 4-2 loss to the New York Mets in the winner-take-all Game 3 of the National League wild-card series was the latest blow for a franchise that has experienced nothing ...

In response to a lawsuit, the FDA has said that it will reevaluate its previous decision to remove tirzepatide from its ...

Weight loss jabs are not a “holy grail” and will not solve the obesity crisis on their own, England’s top doctor has said.

Eli Lilly's weight-loss drug is no longer on the Food and Drug Administration's drug shortage list. Compounding pharmacies say this will limit patient access.